Evidence for serotonin synthesis-dependent regulation of in vitro neuronal firing rates in the midbrain raphe complex

European Journal of Pharmacology

Volumn 590, Issue 1-3, 2008, Pages 136-149

  Evans, Andrew K ^a,c   Reinders, Niels ^a   Ashford, Katie A ^a,b   Christie, Isabel N ^a   Wakerley, Jonathan B ^b   Lowry, Christopher A ^a,c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

5 HT1A autoreceptor; Dorsal raphe nucleus; MDMA; Serotonin; Tryptophan; Tryptophan hydroxylase

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PARGYLINE; SEROTONIN; SEROTONIN 1A RECEPTOR; TRYPTOPHAN;

ANIMAL TISSUE; ARTICLE; AUTOREGULATION; BRAIN SLICE; BRAIN TISSUE; CEREBROSPINAL FLUID; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; MALE; MENTAL DISEASE; MESENCEPHALON; METABOLITE; MICRODISSECTION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; STRESS; SYNTHESIS; TIME; WISTAR RAT;

5-HYDROXYTRYPTOPHAN; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; HYDRAZINES; HYDROXYINDOLEACETIC ACID; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; PARGYLINE; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, WISTAR; SEROTONIN; TIME FACTORS; TRYPTOPHAN;

EID: 48049099909     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.06.014     Document Type: Article

References (84)

1. Bach-Mizrachi H., Underwood M.D., Kassir S.A., Bakalian M.J., Sibille E., Tamir H., Mann J.J., and Arango V. Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 31 (2006) 814-824
2. Bach-Mizrachi H., Underwood M.D., Tin A., Ellis S.P., Mann J.J., and Arango V. Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides. Mol. Psychiatry 13 (2008) 507-513
3. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
4. Beck S.G., Pan Y.Z., Akanwa A.C., and Kirby L.G. Median and dorsal raphe neurons are not electrophysiologically identical. J. Neurophysiol. 91 (2004) 994-1005
5. Boadle-Biber M.C. Regulation of serotonin synthesis. Prog. Biophys. Mol. Biol. 60 (1993) 1-15
6. Boldrini M., Underwood M.D., Mann J.J., and Arango V. More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res. 1041 (2005) 19-28
7. Bonkale W.L., Turecki G., and Austin M.C. Increased tryptophan hydroxylase immunoreactivity in the dorsal raphe nucleus of alcohol-dependent, depressed suicide subjects is restricted to the dorsal subnucleus. Synapse 60 (2006) 81-85
8. Brown S.M., Peet E., Manuck S.B., Williamson D.E., Dahl R.E., Ferrell R.E., and Hariri A.R. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol. Psychiatry 10 (2005) 884-888
9. Canli T., Congdon E., Gutknecht L., Constable R.T., and Lesch K.P. Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. J. Neural Transm. 112 (2005) 1479-1485
10. Carlsson A., and Lindqvist M. Accumulation of 5-hydroxytryptophan in mouse brain after decarboxylase inhibition. J. Pharm. Pharmacol. 22 (1970) 726-727
11. Carlsson A., Davis J.N., Kehr W., Lindqvist M., and Atack C.V. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275 (1972) 153-168
12. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2003) 235-272
13. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res. Brain Res. Rev. 18 (1993) 1-32
14. Craven R., Grahame-Smith D., and Newberry N. WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones. Eur. J. Pharmacol. 271 (1994) R1-R3
15. Day H.E., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., and Campeau S. Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J. Comp. Neurol. 474 (2004) 364-378
16. de Kock C.P., Cornelisse L.N., Burnashev N., Lodder J.C., Timmerman A.J., Couey J.J., Mansvelder H.D., and Brussaard A.B. NMDA receptors trigger neurosecretion of 5-HT within dorsal raphe nucleus of the rat in the absence of action potential firing. J. Physiol. 577 (2006) 891-905
17. Dilts R.P., and Boadle-Biber M.C. Differential activation of the 5-hydroxytryptamine-containing neurons of the midbrain raphe of the rat in response to randomly presented inescapable sound. Neurosci. Lett. 199 (1995) 78-80
18. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Greer P.J., and Mathis C. Serotonin type-1A receptor imaging in depression. Nucl. Med. Biol. 27 (2000) 499-507
19. Eisensamer B., Rammes G., Gimpl G., Shapa M., Ferrari U., Hapfelmeier G., Bondy B., Parsons C., Gilling K., Zieglgansberger W., Holsboer F., and Rupprecht R. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol. Psychiatry 8 (2003) 994-1007
20. Elks M.L., Youngblood W.W., and Kizer J.S. Serotonin synthesis and release in brain slices: independence of tryptophan. Brain Res. 172 (1979) 471-486
21. Fisher P.M., Meltzer C.C., Ziolko S.K., Price J.C., and Hariri A.R. Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat. Neurosci. 9 (2006) 1362-1363
22. Fornal C.A., Litto W.J., Metzler C.W., Marrosu F., Tada K., and Jacobs B.L. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats. J. Pharmacol. Exp. Ther. 270 (1994) 1345-1358
23. Fornal C.A., Metzler C.W., Gallegos R.A., Veasey S.C., McCreary A.C., and Jacobs B.L. WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J. Pharmacol. Exp. Ther. 278 (1996) 752-762
24. Friedman P.A., Kappelman A.H., and Kaufman S. Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. J. Biol. Chem. 247 (1972) 4165-4173
25. Gallager D.W., and Aghajanian G.K. Inhibition of firing of raphe neurones by tryptophan and 5-hydroxytryptophan: blockade by inhibiting serotonin synthesis with Ro-4-4602. Neuropharmacology 15 (1976) 149-156
26. Garcia-Colunga J., Awad J.N., and Miledi R. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc. Natl. Acad. Sci. U. S. A, 94 (1997) 2041-2044
27. Gardner K.L., Thrivikraman K.V., Lightman S.L., Plotsky P.M., and Lowry C.A. Early life experience alters behavior during social defeat: focus on serotonergic systems. Neuroscience 136 (2005) 181-191
28. Gartside S.E., Umbers V., Hajos M., and Sharp T. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115 (1995) 1064-1070
29. Gartside S.E., McQuade R., and Sharp T. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems. Neuropharmacology 36 (1997) 1697-1703
30. Gartside S.E., Umbers V., and Sharp T. Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms. Psychopharmacology (Berl) 130 (1997) 261-268
31. Graeff F.G., Viana M.B., and Mora P.O. Dual role of 5-HT in defense and anxiety. Neurosci. Biobehav. Rev. 21 (1997) 791-799
32. Gray J.A., and McNaughton N. The Neuropsychology of Anxiety. Second Edition (2000), Oxford Medical Publications, Oxford
33. Haghighi F., Bach-Mizrachi H., Huang Y.Y., Arango V., Shi S., Dwork A.J., Rosoklija G., Sheng H.T., Morozova I., Ju J., Russo J.J., and Mann J.J. Genetic architecture of the human tryptophan hydroxylase 2 gene: existence of neural isoforms and relevance for major depression. Mol. Psychiatry (2008) (in press, advance online publication)
34. Hajos M., Hoffmann W.E., Tetko I.V., Hyland B., Sharp T., and Villa A.E. Different tonic regulation of neuronal activity in the rat dorsal raphe and medial prefrontal cortex via 5-HT(1A) receptors. Neurosci. Lett. 304 (2001) 129-132
35. Hashimoto M., Miyamae T., Yamamoto I., and Goshima Y. DOPA cyclohexyl ester potently inhibits aglycemia-induced release of glutamate in rat striatal slices. Neurosci. Res. 45 (2003) 335-344
36. Huang C.C., Tsai J.J., and Hsu K.S. -deprenyl (selegiline) limits the repetitive firing of action potentials in rat hippocampal CA1 neurons via a dopaminergic mechanism. Brain Res. 753 (1997) 27-35
37. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72 (1992) 165-229
38. Jacobs B.L., and Fornal C.A. Activity of brain serotonergic neurons in the behaving animal. Pharmacol. Rev. 43 (1991) 563-578
39. Johnson D.A., Gartside S.E., and Ingram C.D. 5-HT1A receptor-mediated autoinhibition does not function at physiological firing rates: evidence from in vitro electrophysiological studies in the rat dorsal raphe nucleus. Neuropharmacology 43 (2002) 959-965
40. Kecskemeti V., Rusznak Z., Riba P., Pal B., Wagner R., Harasztosi C., Nanasi P.P., and Szucs G. Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies. Brain Res. Bull. 67 (2005) 126-132
41. Kim H.J., Choi J.S., Lee Y.M., Shim E.Y., Hong S.H., Kim M.J., Min D.S., Rhie D.J., Kim M.S., Jo Y.H., Hahn S.J., and Yoon S.H. Fluoxetine inhibits ATP-induced [Ca(2+)](i) increase in PC12 cells by inhibiting both extracellular Ca(2+) influx and Ca(2+) release from intracellular stores. Neuropharmacology 49 (2005) 265-274
42. Kirby L.G., Pernar L., Valentino R.J., and Beck S.G. Distinguishing characteristics of serotonin and non-serotonin-containing cells in the dorsal raphe nucleus: electrophysiological and immunohistochemical studies. Neuroscience 116 (2003) 669-683
43. Kuhar M.J., Aghajanian G.K., and Roth R.H. Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: correlations with serotonin levels and histochemical fluorescence. Brain Res. 44 (1972) 165-176
44. Kuhn D.M., Ruskin B., and Lovenberg W. Tryptophan hydroxylase. The role of oxygen, iron, and sulfhydryl groups as determinants of stability and catalytic activity. J. Biol. Chem. 255 (1980) 4137-4143
45. Liu R.J., Lambe E.K., and Aghajanian G.K. Somatodendritic autoreceptor regulation of serotonergic neurons: dependence on l-tryptophan and tryptophan hydroxylase-activating kinases. Eur. J. Neurosci. 21 (2005) 945-958
46. Lookingland K.J., Shannon N.J., Chapin D.S., and Moore K.E. Exogenous tryptophan increases synthesis, storage, and intraneuronal metabolism of 5-hydroxytryptamine in the rat hypothalamus. J. Neurochem. 47 (1986) 205-212
47. Lopez V.A., tera-Wadleigh S., Cardona I., Kassem L., and McMahon F.J. Nested association between genetic variation in tryptophan hydroxylase II, bipolar affective disorder, and suicide attempts. Biol. Psychiatry 61 (2007) 181-186
48. Lowry C.A. Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J. Neuroendocrinol. 14 (2002) 911-923
49. Lowry C.A., Rodda J.E., Lightman S.L., and Ingram C.D. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J. Neurosci. 20 (2000) 7728-7736
50. Lowry C.A., Johnson P.L., Hay-Schmidt A., Mikkelsen J., and Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress 8 (2005) 233-246
51. Lucki I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry 44 (1998) 151-162
52. Maier S.F., and Watkins L.R. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci. Biobehav. Rev. 29 (2005) 829-841
53. Marinelli S., Schnell S.A., Hack S.P., Christie M.J., Wessendorf M.W., and Vaughan C.W. Serotonergic and nonserotonergic dorsal raphe neurons are pharmacologically and electrophysiologically heterogeneous. J. Neurophysiol. 92 (2004) 3532-3537
54. McEuen J.G., and Bale T.L. Chronic stress induces alterations in serotonin-related gene expression in a model of CRF dysregulation. Program No.505.1.2006 Abstract Viewer/Itinerary Planner (2006), Society for Neuroscience, Atlanta, GA Online
55. McKinney J., Knappskog P.M., and Haavik J. Different properties of the central and peripheral forms of human tryptophan hydroxylase. J. Neurochem. 92 (2005) 311-320
56. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70 (2003) 83-244
57. Millan M.J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 110 (2006) 135-370
58. Mlinar B., Tatini F., Ballini C., Nencioni S., Della C.L., and Corradetti R. Differential autoinhibition of 5-hydroxytryptamine neurons by 5-hydroxytryptamine in the dorsal raphe nucleus. Neuroreport 16 (2005) 1351-1355
59. Mundey M.K., Fletcher A., and Marsden C.A. Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing. Br. J. Pharmacol. 117 (1996) 750-756
60. Neumeister A., Bain E., Nugent A.C., Carson R.E., Bonne O., Luckenbaugh D.A., Eckelman W., Herscovitch P., Charney D.S., and Drevets W.C. Reduced serotonin type 1A receptor binding in panic disorder. J. Neurosci. 24 (2004) 589-591
61. Palkovits M., and Brownstein M. Maps and Guide to Microdissection of the Rat Brain (1988), Elsevier, New York
62. Partilla J.S., Dempsey A.G., Nagpal A.S., Blough B.E., Baumann M.H., and Rothman R.B. Interaction of amphetamines and related compounds at the vesicular monoamine transporter. J. Pharmacol. Exp. Ther. 319 (2006) 237-246
63. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fifth ed. (2005), Academic Press, San Diego
64. Peters E.J., Slager S.L., McGrath P.J., Knowles J.A., and Hamilton S.P. Investigation of serotonin-related genes in antidepressant response. Mol. Psychiatry 9 (2004) 879-889
65. Petersen R. Design and Analysis of Experiments (1985), Marcel Dekker, Inc., New York
66. Raffel D.M., and Wieland D.M. Influence of vesicular storage and monoamine oxidase activity on [11C]phenylephrine kinetics: studies in isolated rat heart. J. Nucl. Med. 40 (1999) 323-330
67. Reinhard Jr. J.F., and Wurtman R.J. Relation between brain 5-HIAA levels and the release of serotonin into brain synapses. Life Sci. 21 (1977) 1741-1746
68. Renner K.J., and Luine V.N. Determination of monoamines in brain nuclei by high performance liquid chromatography with electrochemical detection: young vs. middle aged rats. Life Sci. 34 (1984) 2193-2199
69. Romero L., Celada P., Martin-Ruiz R., az-Mataix L., Mourelle M., Delgadillo J., Hervas I., and Artigas F. Modulation of serotonergic function in rat brain by VN2222, a serotonin reuptake inhibitor and 5-HT1A receptor agonist. Neuropsychopharmacology 28 (2003) 445-456
70. Ruddick J.P., Evans A.K., Nutt D.J., Lightman S.L., Rook G.A., and Lowry C.A. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev. Mol. Med. 8 (2006) 1-27
71. Schuldiner S., Steinermordoch S., Yelin R., Wall S.C., and Rudnick G. Amphetamine derivatives interact with both plasma-membrane and secretory vesicle biogenic-amine transporters. Mol. Pharmacol. 44 (1993) 1227-1231
72. Sharp T., Gartside S.E., and Umbers V. Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT1A receptor antagonist on 5-hydroxytryptamine cell firing and release. Eur. J. Pharmacol. 320 (1997) 15-19
73. Sprouse J.S., Bradberry C.W., Roth R.H., and Aghajanian G.K. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin. Eur. J. Pharmacol. 167 (1989) 375-383
74. Sprouse J.S., Bradberry C.W., Roth R.H., and Aghajanian G.K. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by l-tryptophan. Eur. J. Pharmacol. 178 (1990) 313-320
75. Steinbusch H.W.M. Distribution of serotonin-immunoreactivity in the central nervous-system of the rat - cell-bodies and terminals. Neuroscience 6 (1981) 557-618
76. Taylor J.D., Wykes A.A., Gladish Y.C., and Martin W.B. New inhibitor of monoamine oxidase. Nature 187 (1960) 941-942
77. Ten Eyck G.R., Ronan P.J., Renner K.J., and Summers C.H. Serotonin metabolism in directly developing frog embryos during paternal care. Neurosci. Lett. 388 (2005) 100-105
78. Trulson M.E., and Crisp T. Calcium regulates the activity of serotonin-containing dorsal raphe neurons in vitro. Brain Res. Bull. 15 (1985) 107-110
79. Trulson M.E., and Frederickson C.J. A comparison of the electrophysiological and pharmacological properties of serotonin-containing neurons in the nucleus raphe dorsalis, raphe medianus and raphe pallidus recorded from mouse brain slices in vitro: role of autoreceptors. Brain Res. Bull. 18 (1987) 179-190
80. Trulson M.E., and Jacobs B.L. Dose-response relationships between systemically administered l-tryptophan or l-5-hydroxytryptophan and raphe unit activity in the rat. Neuropharmacology 15 (1976) 339-344
81. Underwood M.D., Khaibulina A.A., Ellis S.P., Moran A., Rice P.M., Mann J.J., and Arango V. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol. Psychiatry 46 (1999) 473-483
82. Vandermaelen C.P., and Aghajanian G.K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 289 (1983) 109-119
83. Vasey M.W., and Thayer J.F. The continuing problem of false positives in repeated measures ANOVA in psychophysiology: a multivariate solution. Psychophysiology 24 (1987) 479-486
84. Zill P., Baghai T.C., Zwanzger P., Schule C., Eser D., Rupprecht R., Moller H.J., Bondy B., and Ackenheil M. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol. Psychiatry 9 (2004) 1030-1036